Earnings Standouts: 52 Stocks Outperforming Wall Street Estimates
Research by the Bank for International Settlements said that equity markets tend to already price in earnings expectations well before official results are announced.
Posts Tagged ‘NASDAQ:ARVN’
Arvinas, Inc. (NASDAQ:ARVN) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Arvinas First Quarter 2026 Earnings Call.
Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials
Arvinas Inc. (NASDAQ:ARVN) is one of the best cancer stocks to invest in now. On February 24, Arvinas Inc.
11 Best Cancer Stocks to Invest In Now
Pharmaceutical companies are a blend of defensive income plays and growth opportunities.
Arvinas, Inc. (NASDAQ:ARVN) Q4 2025 Earnings Call Transcript
Arvinas, Inc. (NASDAQ:ARVN) Q4 2025 Earnings Call Transcript February 24, 2026Arvinas, Inc. misses on earnings expectations.
Arvinas, Inc. (NASDAQ:ARVN) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Arvinas Third Quarter 2025 Earnings Call. I'd like to remind everyone that this call is being recorded.
Arvinas, Inc. (NASDAQ:ARVN) Stake Jumps 194% at XTX Topco
Arvinas, Inc. (NASDAQ:ARVN) is among the best US stocks under $10 to invest in. XTX Topco Ltd has increased its stake in Arvinas, Inc.
8 Best US Stocks Under $10 to Invest in
Everyone seeks a stock that has good upside potential, but a stock that is cheap and has good prospects - that’s what a steal deal looks like.
Arvinas, Pfizer’s Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment
Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in collaboration with Pfizer Inc.
9 Best Small Cap Stocks with Biggest Upside Potential
On August 14, Jonathan Krinsky of BTIG, joined 'Closing Bell' on CNBC to discuss whether the recent rally in small cap stocks is sustainable.
Arvinas, Inc. (NASDAQ:ARVN) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I would like to welcome everyone to Arvinas' Second Quarter 2025 Earnings Call.
Arvinas, Inc. (ARVN): A Bull Case Theory
This stock is one of several featured in our latest research.
10 Promising SmallCap Stocks Under $1 Billion Market Cap
SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those willing to dig deeper.
Arvinas Presents Promising Preclinical Data for BCL6 Degrader ARV-393 in Lymphoma Treatment
Arvinas Inc. (NASDAQ:ARVN) is one of the best low priced pharma stocks to buy now.
13 Best Low Priced Pharma Stocks to Buy Now
On July 9, Afsaneh Beschloss, RockCreek Group founder & CEO, joined 'Closing Bell Overtime' on CNBC to talk about the latest round of tariff threats.
Arvinas, Inc. (NASDAQ:ARVN) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Gail and I will be the operator for today's call.
Here are 1 Main Capital Partners’ Views on Arvinas (ARVN)
1 Main Capital, a boutique investment firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
10 Pump and Dump Stocks Favored by Hedge Funds
Pump and dump stocks are typically characterized by high 52-week volatility, often experiencing rapid price surges followed by sharp declines.
Arvinas, Inc. (NASDAQ:ARVN) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Arvinas Fourth Quarter 2024 Earnings Conference Call.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
10 Best Small-Cap Stocks Ready To Explode
On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, discussed the outperformance ...
Arvinas, Inc. (NASDAQ:ARVN) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I'd like to welcome everyone to Arvinas Third Quarter 2024 Earnings Call.
8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
Top 10 Small-Cap Stocks with Highest Upside Potential
Small-cap stocks are companies with a market capitalization of somewhere between $250 million and $2 billion.
12 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the 12 most promising cancer stocks according to analysts.
Wall Street Analysts Trim Price Targets for These 10 Stocks
In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts.
5 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 5 stocks with biggest upside potential according to analysts.
12 Cash-Rich Small Cap Stocks To Invest In
In 2022, standard diversified portfolios suffered through their worst-performing year in a century.
5 Best Small-Cap Healthcare Stocks To Buy Now
In this article, we discuss 5 best small-cap healthcare stocks to buy now.
15 Small Company Stocks You Should Own Now for the Next Decade
In this article, we discuss 15 small company stocks you should own now for the next decade.
Should I Avoid Arvinas, Inc. (ARVN)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is Arvinas, Inc. (ARVN) Going to Burn These Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Hedge Funds Are Dumping Arvinas, Inc. (ARVN)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Is ARVN Stock A Buy or Sell?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Hedge Fund and Insider Trading News: Marc Lasry, Anthony Scaramucci, Ray Dalio, Izzy Englander, Bill Ackman, Arvinas Inc (ARVN), Tradeweb Markets Inc (TW), and More
New York (CNN Business) Ray Dalio, the billionaire founder of the world's largest hedge fund, is deeply worried about a divided and profoundly unequal America as President-elect...
Hedge Funds Have Never Been This Bullish On Arvinas, Inc. (ARVN)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Arvinas, Inc. (ARVN) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Fund and Insider Trading News: Bill Ackman, Ken Griffin, Millennium Management, CQS Cayman LP, Polar Capital, Dollarama Inc (DLMAF), and More
NEW YORK/BOSTON (Reuters) - Billionaire investor William Ackman, whose hedge fund is delivering some of the year’s best returns, said on Monday he was looking to raise $3 billion...
Here is What Hedge Funds Think About Arvinas, Inc. (ARVN)
In this article you are going to find out whether hedge funds think Arvinas, Inc. (NASDAQ:ARVN) is a good investment right now.
Were Hedge Funds Right About Arvinas, Inc. (ARVN)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Did Hedge Funds Drop The Ball On Arvinas, Inc. (NASDAQ:ARVN) ?
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong.
Hedge Fund and Insider Trading News: Stanley Druckenmiller, Ray Dalio, Glenview Capital Management, Paulson & Co., Universal Health Services, Inc. (UHS), Ormat Technologies, Inc. (ORA), and More
PointState Capital, the macro hedge fund started by former traders for billionaire Stan Druckenmiller, is looking for new investors as it struggles to rebound from last year’...
Hedge Funds Are Selling Arvinas, Inc. (ARVN)
Is Arvinas, Inc. (NASDAQ:ARVN) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Is Arvinas, Inc. (ARVN) A Good Stock To Buy?
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.
Did Hedge Funds Drop The Ball On Arvinas, Inc. (ARVN) ?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Hedge Fund and Insider Trading News: Andreas Halvorsen, Bill Ackman, Paulson & Co., Merck & Co., Inc. (MRK), Arvinas Inc (ARVN), Y-mAbs Therapeutics (YMAB), and More
Andreas Halvorsen’s Viking Global Investors disclosed Thursday that it holds a 75.6% stake in urologic biopharmaceutical company Urovant Sciences Ltd.
Hedge Fund Resource Center
